ASPG and alkaline phosphatase measurement: Multi-factor analysis showed that protein kinase inhibitors (Ponatinib, Nilotinib, Lenvatinib, Sorafenib), immune checkpoint inhibitors (Nivolumab, Pembrolizumab), L-asparaginase and Pegaspargase were risk factors for inducing drug-related AP.